MAPT and Alzheimer disease: Even within a single disease, neurotransmitters may have stage‐specific effects: α7 nicotinic ACh receptors (α7‐nAChR) reduce β‐amyloid (Aβ) accumulation in early Alzheimer's disease (AD) [7], but worsen tau hyperphosphorylation in later stages [8].